What Analysts Are Saying About WAVE Life Sciences Stock
What Analysts Are Saying About WAVE Life Sciences Stock
关于Wave Life Sciences股票的分析师意见
During the last three months, 4 analysts shared their evaluations of WAVE Life Sciences (NASDAQ:WVE), revealing diverse outlooks from bullish to bearish.
在过去的三个月中，4位分析师分享了他们对创业板（NASDAQ:WVE）的评估，展现了从看好到看淡的不同观点。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级概况，突出了过去30天内情绪的变化，并将其与之前的月份进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $15.5, a high estimate of $19.00, and a low estimate of $11.00. Observing a downward trend, the current average is 8.82% lower than the prior average price target of $17.00.
通过对12个月价格目标的评估，分析师提供了更深入的见解，揭示了平均目标价为15.5美元，最高估计为19.00美元，最低估计为11.00美元的价格目标。经过观察发现，当前的平均目标价比之前的17.00美元的平均目标价降低了8.82%。
Diving into Analyst Ratings: An In-Depth Exploration
深入探讨分析师评级：分析师评级的深度探讨
The standing of...
通过对...
登录免费看全文
登录/注册